Dr. Kim Papp

Dr. Kim Papp has a general dermatology practice and clinical research center in Waterloo, Ontario,
Canada. He is a Member of the College of Physicians and Surgeons of Ontario, a Fellow of the Royal
College of Physicians and Surgeons of Canada, a Fellow of the American Academy of Dermatology, and an Adjunct Professor of Medicine as Temerty Faculty of Medicine at the University of Toronto.

He has over 25 years of experience as a Principal Investigator across various indications including
psoriasis – for which he is best known, atopic dermatitis, lichen sclerosis et atrophicus, urticaria, vitiligo, alopecia areata, psoriatic arthritis, and others.

Dr. Papp, with the support of Probity Medical Research, an organization for which he is Founder and
President, has become one of the world’s leading experts in the treatment of psoriasis and atopic
dermatitis.

Dr. Papp is a consultant or advisor for over 65 pharmaceutical and biotech companies.
His academic interest in the assessment of disease severity measures, the impact of bias and error on clinical assessment, clinical trial design, pharmacokinetics/ pharmacodynamics, and the development of meaningful clinical guidelines and treatment targets, is partially reflected in over 500 publications.